Top Markets
#1 Black Phoenix Black Phoenix +21,573.64%
#2 Nesa Nesa +775.50%
#3 Cortex Cortex +69.18%
#4 Kinesis Silver Kinesis Silver +55.36%
#5 QuantixAI QuantixAI +23.71%
#6 EXOD EXOD +22.78%
#7 Pons Pons +20.39%
#8 Derive Derive +19.90%
#9 Cash Cat Cash Cat +17.42%
#10 BNB Attestation Service BNB Attestation Service +16.09%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Classement en actions #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Prix de l'action
$4.62
Dernière synchronisation: 2023-03-23
Capitalisation boursière
$171.76M
Changement (1 jour)
-37.16%
Changement (1 an)
0.00%
Pays
KR
Échange Cellivery Therapeutics, Inc. (268600)

Catégorie

Healthcare
Ratio P/S pour Cellivery Therapeutics, Inc. (268600)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Cellivery Therapeutics, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Cellivery Therapeutics, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH